XML 27 R14.htm IDEA: XBRL DOCUMENT v3.4.0.3
Marketable Securities
3 Months Ended
Mar. 31, 2016
Investments, Debt and Equity Securities [Abstract]  
Marketable Securities
Marketable Securities

 
Cost
 
Unrealized
Gains
 
Unrealized
Losses
 
Fair
Value
 
(In millions)
 
 
 
 
 
 
 
 
March 31, 2016
 
 
 
 
 
 
 
United States government obligations
 
 
 
 
 
 
 
Maturity less than 1 year
$
297

 
$

 
$

 
$
297

Maturity 1 to 5 years
99

 
1

 

 
100

Corporate debt securities
 

 
 

 
 

 
 

Maturity 1 to 5 years
69

 
1

 

 
70

Other debt securities
 

 
 

 
 

 
 

Maturity less than 1 year
228

 

 

 
228

Maturity 1 to 5 years

 

 

 

Equity securities
 
 
 

 
 

 
 

Available-for-sale
309

 

 
(38
)
 
271

 
$
1,002

 
$
2

 
$
(38
)
 
$
966


 
Cost
 
Unrealized
Gains
 
Unrealized
Losses
 
Fair
Value
 
(In millions)
 
 
 
 
 
 
 
 
December 31, 2015
 
 
 
 
 
 
 
United States government obligations
 
 
 
 
 
 
 
Maturity less than 1 year
$
256

 
$

 
$

 
$
256

Maturity 1 to 5 years
116

 

 

 
116

Corporate debt securities
 

 
 

 
 

 
 

Maturity 1 to 5 years
26

 

 

 
26

Other debt securities
 

 
 

 
 

 
 

Maturity less than 1 year
182

 

 

 
182

Maturity 1 to 5 years
3

 

 

 
3

Equity securities
 

 
 

 
 

 
 

Available-for-sale
296

 
4

 
(6
)
 
294

 
$
879

 
$
4

 
$
(6
)
 
$
877



Of the $38 million in unrealized losses at March 31, 2016, $35 million arose within the last 12 months and is related to the Company’s investment in two available-for-sale equity securities with a fair value of $267 million.  The market value of the Company’s investment that has been in an unrealized loss position for 12 months or longer is $3 million and is related to one available-for-sale equity security. The Company evaluated the near-term prospects of the issuers in relation to the severity and duration of the impairment.  Based on that evaluation and the Company’s ability and intent to hold these investments for a reasonable period of time sufficient for a forecasted recovery of fair value, the Company does not consider these investments to be other-than-temporarily impaired at March 31, 2016.